Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women

Menopause

Volumn 14, Issue 5, 2007, Pages 859-865

  Santoro, Nanette ^a   Lo, Yungtai ^b   Moskaleva, Galina ^b   Arnsten, Julia H ^b   Floris Moore, Michelle ^b   Howard, Andrea A ^b   Adel, Goli ^a   Zeitlian, Gohar ^a   Schoenbaum, Ellie E ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Drug use and perimenopause; Follicle stimulating hormone; Highly active antiretroviral therapy; Human immunodeficiency virus infection; Luteinizing hormone; Menopause transition

Indexed keywords

COCAINE; ESTRADIOL; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; OPIATE; PROLACTIN; PROTEINASE INHIBITOR; THYROTROPIN;

ADULT; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; FEMALE; FEMALE GENITAL SYSTEM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MULTIVARIATE ANALYSIS; POSTMENOPAUSE; PREMENOPAUSE; PSYCHOSOCIAL CARE; SELF EVALUATION; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

COMORBIDITY; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADAL STEROID HORMONES; HIV INFECTIONS; HUMANS; INHIBINS; LUTEINIZING HORMONE; MENOPAUSE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW YORK CITY; PROLACTIN; PROSPECTIVE STUDIES; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; THYROTROPIN;

EID: 34948888141     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31802f7369     Document Type: Article

References (40)

1. Pallela FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-860.
2. Santoro N. What a SWAN can teach us about menopause. Contemp Obstet/Gynecol 2004;49:11-15.
3. Karon JM, Fleming PL, Steketee RW, De Cock KM. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health 2001;91:1060-1068.
4. National Institute of Allergy and Infectious Diseases. Fact sheet: HIV infection in women. Available at: http://www.niaid.nih.gov/factsheets/womenhiv. htm. Accessed May 2006.
5. Brambilla DJ, McKinlay SM, Johannes CB. Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol 1994;140:1091-1095.
6. World Health Organization. Report of a WHO Scientific Working Group. Research on the Menopause in the 1990s. WHO Technical Report, Series 866. Geneva: WHO, 1996.
7. Mitchell ES, Woods NF. Symptom experiences of midlife women: observations from the Seattle Midlife Women's Health Study. Maturitas 1996;25:1-10.
8. Wilbur J, Miller AM, Montgomery A, Chandler P. Sociodemographic characteristics, biological factors, and symptom reporting in midlife women. Menopause 1998;5:43-51.
9. Gold E, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463-473.
10. Dennerstein L, Smith AMA, Morse C, et al. Menopausal symptoms in Australian women. Med J Aust 1993;159:232-236.
11. Hunter M, Battersby R, Whitehead M. Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas 1986;8:217-228.
12. Miller SA, Santoro N, Lo Y, et al. Menopause symptoms in HIV-infected and drug-using women. Menopause 2005;12:348-356.
13. Yeni PG, Hammer SM, Carpenter CCJ, et al. Antiretroviral treatment for adult HIV infection in 2002. JAMA 2002;288:222-235.
14. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement 1977;1:385-401.
15. Comstock GW, Helsing KJ. Symptoms of depression in two communities. Psychol Med 1976;4:551-563.
16. Moore J, Schuman P, Boland B, Solomon L, Smith D. Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America. AIDS 1999;13:2459-2468.
17. Wilshire GB, Loughlin JS, Brown JR, Adel TE, Santoro N. Diminished function of the somatotropic axis in older reproductive-aged women. J Clin Endocrinol Metab 1995;80:608-613.
18. Santoro N, Adel T, Skurnick JH. Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil Steril 1999;71:658-662.
19. Burger HG, Dudley EC, Hopper JL, et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 1999;84:4025-4030.
20. Burger HG, Cahir N, Robertson DM, et al. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol (Oxf) 1998;48:809-813.
21. Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995;21:103-113.
22. Randolph JF, Sowers MF, Gold EB, et al. Reproductive hormones in the early menopausal transition: effects of ethnicity, body size and menopausal status. J Clin Endocrinol Metab 2003;88:1516-1522.
23. McKinlay SM. The normal menopause transition: an overview. Maturitas 1996;23:137-145.
24. Hall JE, Schoenfeld DA, Martin KA, Crowley WF Jr. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition. J Clin Endocrinol Metab 1992;74:600-607.
25. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727.
26. Grenman S, Ronnemaa T, Irjala K, Kaihola HL, Gronroos M. Sex steroid, gonadotropin, cortisol, and prolactin levels in healthy, massively obese women: correlation with abdominal fat cell size and effect of weight reduction. J Clin Endocrinol Metab 1986;63:1257-1261.
27. Sherman BM, Korenman SG. Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase. J Clin Endocrinol Metab 1974;39:145-149.
28. Cortet-Rudelli C, Pigny P, Decanter C, et al. Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome. Fertil Steril 2002;77:281-287.
29. Battistini M, Freeman EW, Grisso JA, Sammel M, Hollander L, Garcia-Espana B. Pilot study of racial differences and longitudinal changes in inhibin B in the late reproductive years. Fertil Steril 2002;77:193-195.
30. Santoro N, Schoenbaum E, Arnsten J, Buono D. Impact of street drug use, HIV infection and highly active antiretroviral drugs on reproductive hormones in middle aged women. J Womens Health 2005;14:898-905.
31. Willenbring ML, Morley JE, Krahn DD, Carlson GA, Levine AS, Shafer RB. Psychoneuroendocrine effects of methadone maintenance. Psychoneuroendocrinology 1989;14:371-391.
32. Ragni G, DeLauretis L, Bestetti O, Sghedoni D, Gambaro V. Gonadal function in male heroin and methadone addicts. Int J Androl 1988;11:93-100.
33. Delitalia G, Grossman A, Besser M. Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion. Neruoendocrinology 1983;37:275-279.
34. SpagnoliW, De Venuto G, Mattarei M, Dal Ri P, Miori R. Prolactin and thyrotropin pituitary response to thyrotropin releasing hormone in young female heroin addicts. Drug Alcohol Depend 1987;20:247-254.
35. Montero A, Bottasso OA, Luraghi MR, Giovannoni AG, Sen L. Galactorrhea, hyperprolactinemia and protease inhibitors. Lancet 2001;357:473-474.
36. Izzedine H, Launay-Vacher V, Baumelou A, Deray G. Antiretroviral and immunosuppressive drug-drug interactions: an update. Kidney Int 2004;66:532-541.
37. Cramer DW, Barbieri RL, Fraer AR, Harlow BL. Determinants of early follicular phase gonadotrophin and estradiol concentrations in women of late reproductive age. Hum Reprod 2002;17:221-227.
38. Randolph JF Jr, Sowers M, Bondarenko IV, Harlow SD, Luborsky JL, Little RJ. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 2004;89:1555-1561.
39. Law MR, Cheng R, Hacksahw AK, Allaway S, Hale AK. Cigarette smoking, sex hormones and bone density in women. Eur J Epidemiol 1997;13:553-558.
40. Berta L, Fortunati N, Gennari P, Appendino M, Casella A, Frairia R. Influence of cigarette smoking on pituitary and sex hormone balance in healthy premenopausal women. Fertil Steril 1991;56:788-789.